LXEO
LEXEO (LXEO)
NASDAQ
$4.60+$0.09 (+2.00%)
Price as of Jun 03, 2026 6:51 PM EDT
  • $403.6M
    Market Cap
  • 59.93%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
291,000
+382.52%
-103,000
-115.75%
654,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
291,000
+382.52%
-103,000
-115.75%
654,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-63.8M
-13.89%
-74.1M
+39.45%
-53.1M
N/A
Depreciation and Amortization Expense
268,000
-11.84%
304,000
+12.18%
271,000
N/A
Total Operating Expenses
109.3M
+3.30%
105.8M
+54.37%
68.5M
N/A
Operating Profit
-109.3M
+3.30%
-105.8M
+54.37%
-68.5M
N/A
Interest Income
6.1M
-18.87%
7.6M
+163.55%
2.9M
N/A
Interest Expense
N/A
N/A
N/A
N/A
-205,000
N/A
Interest Income and Expense and Net
6.1M
-18.87%
7.6M
+183.85%
2.7M
N/A
Total Nonoperating Income and Expense
9.3M
+25.06%
7.4M
+250.78%
2.1M
N/A
Income before Taxes
-109.3M
+11.11%
-98.3M
+48.11%
-66.4M
N/A
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-100.0M
+1.66%
-98.3M
+48.11%
-66.4M
N/A
Net Income from Continuing Operations Applicable to Common
-100.0M
+1.66%
-98.3M
+48.11%
-66.4M
N/A
Basic EPS and Net Income
-1.86
-39.81%
-3.09
-75.08%
-12.40
N/A
Diluted EPS and Net Income
-1.86
-39.81%
-3.09
-75.08%
-12.40
N/A
Basic Weighted Average Shares
53.6M
+68.76%
31.8M
+493.67%
5.4M
N/A
Diluted Weighted Average Shares
53.6M
+68.76%
31.8M
+493.67%
5.4M
N/A
Balance Sheet
Cash and Cash Equivalents
63.0M
+79.93%
35.0M
-71.17%
121.5M
N/A
Short-Term Investments
118.8M
+37.30%
86.5M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
181.8M
+49.58%
121.5M
+0.04%
121.5M
N/A
Total Current Assets
188.4M
+49.37%
126.1M
+1.47%
124.3M
N/A
Accumulated Depreciation
741,000
+56.33%
474,000
+24.41%
381,000
N/A
Property and Plant and Equipment and Net
1.1M
+10.80%
1.0M
-2.65%
1.1M
N/A
Total Long-Term Assets
1.1M
+10.80%
1.0M
-2.65%
1.1M
N/A
Total Assets
268.7M
+82.85%
146.9M
+5.10%
139.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
157,000
N/A
Total Short-Term Debt
N/A
N/A
4.4M
0.00%
4.4M
N/A
Total Current Liabilities
16.8M
-26.43%
22.8M
+32.53%
17.2M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
4.9M
-24.13%
6.4M
-17.33%
7.8M
N/A
Total Liabilities
22.0M
-26.85%
30.1M
+14.57%
26.3M
N/A
Retained Earnings
-380.1M
+35.68%
-280.2M
+54.08%
-181.8M
N/A
Total Stockholders Equity
246.7M
+111.11%
116.8M
+2.91%
113.5M
N/A
Total Shares Outstanding
73.0M
+120.74%
33.1M
+24.11%
26.6M
N/A
Cash Flow
Cash from Operating Activities
-98.6M
+21.45%
-81.2M
+36.40%
-59.5M
N/A
Capital Expenditures
397,000
-17.46%
481,000
+318.26%
115,000
N/A
Cash from Investing Activities
-90.3M
-4.07%
-94.1M
+56,916.36%
-165,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
216.8M
+144.20%
88.8M
-14.47%
103.8M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-37,545.36%
-136.56%
102,685.44%
N/A
N/A
N/A
Return on Assets
-48.10%
-29.87%
-68.58%
N/A
N/A
N/A
Return on Equity
-55.00%
-35.58%
-85.37%
N/A
N/A
N/A
Revenue Growth
382.52%
+430.48%
-115.75%
N/A
N/A
N/A
Current Ratio
11.21
+103.03%
5.52
N/A
N/A
N/A
Cash Ratio
3.75
+144.56%
1.53
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow